Bird flu investigator says continuation of research remains 'urgent' despite moratorium

NewsGuard 100/100 Score

Research into transmissible bird flu strains remains "urgent" despite flu investigators' recent declaration of a "60-day moratorium on avian flu transmission because of the current controversy," Yoshihiro Kawaoka of Tokyo University and the University of Wisconsin-Madison, "a lead researcher on one of two recent studies showing how H5N1 can be transmitted through airborne droplets" among ferrets, writes in a commentary published Wednesday in the journal Nature, Reuters reports. In December, the U.S. National Science Advisory Board for Biosecurity "asked two leading journals, Nature and Science, to withhold details of both studies for fear it could be used by bioterrorists," the news agency notes.

In the commentary, "Kawaoka argued it would be 'irresponsible' and dangerous not to continue researching highly pathogenic bird flu viruses" because flu viruses are constantly mutating in the wild, Reuters writes (Kelland, 1/25). Kawaoka also noted that the strain created by his lab was not lethal and was susceptible to current vaccines and treatments, according to Bloomberg Businessweek. The news service writes that the Dutch team, led by Ron Fouchier of Erasmus Medical Center in Rotterdam, "engineered a lethal strain of bird flu that was contagious among laboratory ferrets" (Peterson et al., 1/25).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Expanding research and clinical options for children with cancer